Question 1

What are the main differences between Valganciclovir and Ganciclovir?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes clinical trial (NCT00002377). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes clinical trial (NCT00002377). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from these treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes clinical trial (NCT00002377). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this trial compare to other treatment options I might have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes clinical trial (NCT00002377). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the duration of the treatment and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes clinical trial (NCT00002377). Contact the study team or your healthcare provider for specific answers.

What this study is about